Clinical trials
Gallstones trials in China with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 6 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 8 |
| Completed | 7 |
| Recruiting | 3 |
| Withdrawn | 1 |
| Not yet recruiting | 1 |
| Enrolling by invitation | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatopancreatobiliary Surgery Institute of Gansu Province | 4 |
| Chinese University of Hong Kong | 3 |
| First Affiliated Hospital Xi'an Jiaotong University | 2 |
| Tongji Hospital | 2 |
| Air Force Military Medical University, China | 1 |
| First People's Hospital of Hangzhou | 1 |
| Peking Union Medical College Hospital | 1 |
| Peking University Third Hospital | 1 |
| Piyou Ji | 1 |
| Shandong Linglong Yingcheng Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gallstones | 22 |
| Cholecystitis | 6 |
| Cholangitis | 2 |
| Cholecystolithiasis | 2 |
| Choledochal Cyst | 2 |
| Choledocholithiasis | 2 |
| Stomach Neoplasms | 2 |
| Adenocarcinoma | 1 |
| Cholangiocarcinoma | 1 |
| Cholecystitis, Acute | 1 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.